PROTECTIVE EFFICACY OF SILVER NANOPARTICLES SYNTHESIZED FROM SILYMARIN ON CISPLATIN INDUCED RENAL OXIDATIVE STRESS IN ALBINO RAT by M., Janakiraman
 
 
PROTECTIVE EFFICACY OF SILVER NANOPARTICLES SYNTHESIZED FROM SILYMARIN ON 
CISPLATIN INDUCED RENAL OXIDATIVE STRESS IN ALBINO RAT 
 Original Article 
 
JANAKIRAMAN M. 
Department of Biochemistry, J. J. College of Arts and Science (Autonomous), Pudukkottai, Tamilnadu, India 
Email: mugavaiprofmj@gmail.com 
Received: 19 Jun 2018, Revised and Accepted: 09 Jul 2018 
ABSTRACT 
Objective: This present study was carried out to evaluate the protective efficacy of silver nanoparticles synthesized from silymarin on cisplatin-
induced renal oxidative stress in the albino rat. 
Methods: Silver nanoparticles of silymarin was characterized by particle size, UV-Visible, FTIR and XRD analysis. Albino rats were divided randomly 
into six groups of six animals each. Group I Normal rats were treated with an oral dose of distilled water for 15 d. Group II rats were treated with single i. 
p. dose of cisplatin (16 mg/kg) on day 1. Group III rats were treated only with oral dose of silymarin (50 mg/kg/d) for 15 d. Group IV rats were treated 
only with oral dose of silver nanoparticles of silymarin (50 mg/kg/d) for 15 d. Group V rats were treated with an oral dose of silymarin for 14 d after 
single i. p. dose of cisplatin on day 1. Group VI rats were treated with oral dose of silver nanoparticles of silymarin for 14 d after single i. p. dose of 
cisplatin on day 1. Collected blood samples and kidney tissue samples were used for biochemical, enzymatic antioxidant and histopathological studies in 
all groups.  
Results: The formation of silver nanoparticles of silymarin were confirmed by particle size, UV-Visible analysis, crystalline nature was confirmed by 
X-ray diffraction analysis, and active principles were confirmed by FTIR analysis. Biochemical results of silver nanoparticles of silymarin-treated 
groups showed the significant (p˂0.05) decrease i n the level of creatinine, urea, and uric acid as compared to cisplatin-induced rats and The 
enzymatic antioxidants of silver nanoparticles of silymarin-treated groups showed the significant (p˂0.05) increa se in the level of glutathione 
reductase and significant decrease in MDA level as compared to cisplatin-induced rats. Additionally, histopathological results of silver nanoparticles 
of silymarin-treated groups also confirmed that the ameliorative effect of silymarin nanoparticle against cisplatin-induced rats. 
Conclusion: From this research work, we have concluded that silver nanoparticles of silymarin protected the kidney of albino rats from the adverse 
effects caused by cisplatin. 
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Nephrotoxicity is one of the third most common kidney problems in 
the world and occurs when the body is exposed to a drug or toxin. 
When kidney damage to occurs, body unable to ride of excess urine 
and wastes from the body. It is manifested functionally by tubular 
proteinuria, mild glucosuria, lowering of glomerular filtration rate, 
creatinine clearance and increase in serum blood urea nitrogen [1]. 
Cisplatin and platinum-based therapeutics are now being used for 
the treatment of testicular, head and neck, ovarian, cervical, 
nonsmall cell lung carcinoma, and many other types of cancer [2]. 
The major limiting factor in the use of cisplatin is the side effects in 
normal tissues, which include nephrotoxicity, neurotoxicity, 
ototoxicity, nausea, and vomiting. Despite these efforts, the side 
effects of cisplatin, particularly nephrotoxicity, remain a major factor 
that limits the use and efficacy of cisplatin in cancer therapy [3]. 
Silver is a safe and effective bactericidal metal because it is non-toxic 
to animal cells and highly toxic to bacteria. In recent years, 
nanoparticles have received considerable attention due to their wide 
range of applications in the fields of diagnostics, biomarker, cell 
labeling, antimicrobial agents, pharmaceutical applications, drug 
delivery systems, cancer therapy [4]. Silymarin, a mixture of 
flavonolignans extracted from milk thistle plant (Silybum marianum) 
is a very strong antioxidant compound capable of scavenging both free 
radicals and ROS, and thus it increases the antioxidant potential of 
cells by ameliorating the deleterious effects of free radical reactions 
[5]. Recently, silymarin showed unconventional valuable activities as 
hypocholesterolemic and cardioprotective [6], antidiabetic [7], 
hypolipidemic [8], anti-inflammatory, neuroprotective and anti-
apoptotic [9], anti-aging [10] and nephroprotective effects [11]. 
Moreover, silymarin has been shown to be safe in animal models and 
no significant adverse reactions are reported in human studies [12]. 
However, there are no studies was not yet carried out in this research 
work. Therefore, the present study was carried out to evaluate the 
characterization and protective efficacy of silver nanoparticles of 
silymarin against cisplatin-induced rats. 
MATERIALS AND METHODS 
Drugs and chemicals 
Cisplatin vial was used to induce nephrotoxicity; Silymarin tablets 
were procured from the medical shop, pudukkottai and the silver 
nitrate was purchased from sigma Aldrich chemicals. All other 
chemicals and reagents used in the study were obtained 
commercially and were of analytical grade. 
Synthesis of silver nanoparticles 
1 mmol silver nitrate solution was prepared and used for the synthesis 
of silver nanoparticles. 10 ml of the silymarin solution was added into 
90 ml of aqueous solution of 1 mmol silver nitrate for the reduction 
into Ag+
Characterization of silver nanoparticles 
ions. Immediately after the addition of silver nitrate the colour 
change from green to dark brown was noted periodically. Then the 
solution was incubated at room temperature for further incubation till 
28 h. After incubation, the silver nanoparticles were synthesized from 
the silymarin and centrifuged at 10000 rpm for 20 min, and the pellet 
was used to further analysis [13]. 
Silver nanoparticles of silymarin were characterized by particle size 
analysis described by the method of Abd El-Rahman et al.,(2014) 
[14], UV–Vis spectrophotometer analysis by the method of Jeyanthi 
et al.,(2015) [15], XRD technique by the method of Ahmad et 
al.,(2010) [16] and FTIR spectrophotometer analysis was performed 
by the method of Nanzeen bobby et al., (2012) [17]. 
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Experimental design 
Albino rats were divided randomly into six groups of six animals 
each. Group I: Normal rats were treated with an oral dose of distilled 
water for 15 d. Group II: Rats were treated with single i. p. dose of 
cisplatin (16 mg/kg) on day 1 [18]. Group III: Rats were treated with 
an only oral dose of silymarin (50 mg/kg/d) for 15 d [19]. Group IV: 
Rats were treated only with an oral dose of silver nanoparticles of 
silymarin (50 mg/kg/d) for 15 d. Group V: Rats were treated with 
oral dose of silymarin (50 mg/kg/d) from 2nd day to 15th day for 14 d 
after single i. p. the dose of cisplatin on day 1 Group VI: Rats were 
treated with an oral dose of silver nanoparticles of silymarin from 
2nd day to 15th
The prepared kidney homogenate was used for the analysis of 
Malondialdehyde as a measure of lipid peroxidation by the 
thiobarbituric acid assay method of Beuge and Aust, (1978) [23], 
Renal enzymatic antioxidant of glutathione reductase was done 
according to the procedure of David and Richard,(1983) [24].  
 day for 14 d after single i. p. dose of cisplatin (16 
mg/kg) on day 1. Collected blood sample and kidney tissue sample 
were used for the analysis of biochemical, enzymatic antioxidant and 
histopathological studies in all groups. This study was approved by 
IAEC (1416/PO/a/11/CPCSEA). 
Assessment of renal function  
Biochemical analysis 
The collected serum was used for the assay of urea by the method 
described by Marsh et al.,(1980) [20],uric acid was estimated by 
uricase method of Ito,(2000) [21], Alkaline picrate method by Brod 
and Sirota,(1980) was used to measure serum creatinine [22]. 
Kidney oxidative stress measurements 
Histopathological analysis 
The histopathological studies were also carried out to find out the 
pathological changes in the different experimental groups by the 
method of Ochei and Kolhatkar, (2000) [25]. 
Statistical analysis 
The results were expressed as the mean value±SD. Group 
comparisons were performed by using one-way analysis of 
variance (ANOVA) test. Significant difference between normal 
control and experimental groups were assessed by student′s t -test. 
A probability level of less than 5 % (P<0.05) was considered as 
significant [26]. 
RESULTS AND DISCUSSION 
Characterization of silver nanoparticles  
Particle size analysis 
The particle size of the synthesized silver nanoparticles was 
analyzed using a dynamic light scattering particle size analyzer. 
Particle size analysis was carried out using a standard analysis time, 
and the size of silver nanoparticles was found to range from 275 nm 
to 575 nm and the results were shown in fig. 1. 
  
 
Fig. 1: Graph showing the particle size distribution of silver nanoparticles of silymarin 
 
Uv-visible spectrum analysis 
UV-Vis spectra recorded during synthesis of nanoparticles shows an 
absorption maximum at 199 nm, which is typically attributed to 
plasmon resonance of silver nanoparticles (fig. 2). The nanoparticles 
synthesis reaction was started after the silymarin was introduced 
into aqueous silver nitrate solution. After overnight incubation in 
dark room condition, the colorless reaction mixture was turned into 
a dark brown color due to excitation of surface plasmon resonance 
indicating the biotransformation of ionic silver to reduced silver. 
The reduction of silver ions occurred due to the water-soluble 
compounds present in silymarin [27]. 
 
 
Fig. 2: UV-visible spectrum showing plot of absorbance of silver nanoparticles of silymarin 
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FTIR analysis 
FTIR measurements were performed to identify the biomolecules 
responsible for capping, reducing and stabilizing the silver 
nanoparticles present in silymarin. The results of FTIR spectrum of 
silver nanoparticles of silymarin and its peak values with functional 
groups were represented in fig. 3 and table 1. When the silver 
nanoparticles of silymarin were passed into the FTIR, the functional 
groups of the active components were separated based on its peaks 
ratio. The results of FTIR analysis confirmed the presence of phenol, 
primary amines, alkyl, carboxylic acid, aromatic compound, nitro 
compound, benzene, ether, ester and bromo alkanes compounds 
which showed major peaks at 3841.90,3444.7,2922.76,1709.44, 
1638.53,1512.71,1430.81,1364.64,1274.28,1226.55,1161.32,1069.1
0,897.1,810.6 and 535.09 respectively.  
The obtained results were revealed that the presence of various 
functional groups in the synthesized silver nanoparticles from silymarin 
 
 
Fig. 3: FTIR spectrum of silver nanoparticles of silymarin 
 
Table 1: Functional group analysis of silver nanoparticles of silymarin using FTIR spectroscopy 
S. No. Peak values Bond Functional groups 
1 3841.90 O-H Phenols/Alcohols 
2 3444.76 N-H Primary amines 
3 2922.76 C-H Alkyl 
4 1709.44 C=O Carboxylic acids 
5 1638.53 N-H Primary amines 
6 1512.71 C=C Aromatic 
7 1430.81 P-C Aromatic 
8 1364.64 N-O Nitro compound 
9 1274.28 C-O Carboxylic acid 
10 1226.55 C-O Aromatic ether 
11 1161.32 C-O Esters 
12 1069.10 C-N Aliphatic amines 
13 897.17 C-H Benzene 
14 810.61 C-H Benzene 
15 535.09 C-X Bromo alkanes 
 
X-ray diffraction analysis 
X-ray diffraction was carried out to confirm the crystalline nature of 
the silver nanoparticles. The XRD pattern showed numbers of Bragg 
reflections that may be indexed on the basis of the face-centered 
cubic structure of silver. A comparison of our XRD spectrum (fig. 4) 
with the standard confirmed that the silver particles formed in our 
experiments were in the form of nanocrystals, as evidenced by the 
peaks at 2θ values of 13.03 °, 26.54 °, 30.09 °, 33.23 °,35.85 ° and 
38.04 ° correspondings to (111), (222), (321), (331),(332) and (430) 
Bragg reflections, respectively, which may be indexed based on the 
face-centered cubic structure of silver. X-ray diffraction results 
clearly showed that the silver nanoparticles formed by the reduction 
of Ag+
  
ions by silymarin extract are crystalline in nature. The average 
particle size of silver nanoparticles synthesized by the present green 
method can be calculated using the Debye-Scherrer equation D = 
Kλ/β cosθ; where D is the crystallite size of AgNPs, λ is the 
wavelength of the X-ray source (0.1541 nm) used in XRD, β is the full 
width at half maximum of the diffraction peak, K is the Scherrer 
constant with a value from 0.9 to 1, and θ is the Bragg angle. The 
average crystalline size according to Debye-Scherrer equation 
calculated is found to be 35 nm. 
 
Fig. 4: XRD spectrum of the silver nanoparticle of silymarin 
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Due to numerous applications and advantages of nanoparticles in 
medicinal purposes, the various types of nanoparticle-based devices 
were used in this study. The particle size plays an important role in 
nanoparticle properties and therefore an essential task in property 
characterization of nanoparticles is particle sizing. This study also 
confirmed the average particle size of the silver nanoparticle of 
silymarin and this result agree with Jeyanthi et al.,(2015) who have 
reported that green synthesis of silver nanoparticles from Dracaena 
mahatma leaf extract and its antimicrobial activity [28]. UV-visible 
spectroscopy is one of the main tools to confirm the formation of 
nanoparticles in aqueous solutions. UV-visible spectroscopy often 
provides the means of choice to gauge response in an analysis using 
nanoparticles. It has been further suggested that the spectroscopic 
properties of nanoparticles can provide an indicator of their size 
distribution by fitting the position of the surface plasmon resonance 
to a simple wavelength function [29]. This research work also 
confirmed the formation of silymarin silver nanoparticles in 
aqueous solution by the method of UV-Visible spectroscopy and this 
result was proved with previous studies of Shankar et al.,(2004) on 
rapid synthesis of Au, Ag, and bimetallic Au core-Ag shell 
nanoparticles using Neem (Azadirachta indica) leaf broth [30]. FTIR 
spectrum was used to detect the functional group in the reaction 
mixture and predict their involvement in nanoparticle synthesis. 
This result was revealed that there was a significant change in the 
wave number of free hydroxyl groups and phenolic groups (3841.90 
cm-1
Effect of silver nanoparticles of silymarin L. on biochemical 
markers 
) in a silver nanoparticle of silymarin suggesting that 
polyphenols may be involved in the reduction of silver nitrate and 
further stabilization of silver nanoparticle [31]. As a primary 
characterization tool for obtaining critical features such as crystal 
structure, crystallite size, and strain, x-ray diffraction (XRD) patterns 
have been widely used in nanoparticle research [32]. This research 
work XRD spectrum also confirmed the crystalline nature and 
formation of silver nanoparticles of silymarin. FTIR and X-Ray 
diffraction studies of this work were accordance with Amudha 
Murugan et al.,(2014) on biosynthesis and characterization of silver 
nanoparticles using the aqueous extract of Vitex negundo L. These 
findings of the present study were unveiled the potential efficacy of 
silymarin to reduce Ag ions into Ag nanoparticles [33]. 
Fig. 5 showed that there was a significant (p˂0.05) increase in the 
level of creatinine,urea and uric acid of rats treated with cisplatin 
(Group II) as compared to normal control (Group I). In rats treated 
with cisplatin along with silymarin (Group V), there was a significant 
(p˂0.05) decrease in creatinine, urea and uric acid as compared to 
only cisplatin-treated rats (Group II). However, In rats treated with 
cisplatin with silver nanoparticles of silymarin (Group VI), there was 
a profound and significant (p˂0.05) c hanges in all these serum 
kidney markers as compared to only cisplatin-treated rats (Group II) 
as well as compared to rats treated with cisplatin along with 
silymarin (Group V) and the values were restored near to normal 




Fig. 5: Effect of silver nanoparticles of silymarin on biochemical markers in different experimental groups, all values were expressed as 
mean±SD (n = 6). Statistically significant of *ap<0.05 and *bp<0.05 compared to Normal control group (I), *cp<0.05 compared to cisplatin-
treated group (II) and *d
 
Effect of silver nanoparticles of silymarin on renal oxidative 
stress markers 
p<0.05 compared to cisplatin-treated group (II) and silymarin along with cisplatin-treated group (V), Same 
superscript letters were not significantly (p 0˂.05) different from each other 
The effect of silver nanoparticles of silymarin on lipid peroxidation, 
renal tissue enzyme marker glutathione reductase of the different 
experimental groups were showed in fig. 6. We found that there was 
a significant (p˂ 0.05) increase in the level of lipid peroxidation and 
significant (p˂0.05) decrease in the level of glutathione reductase in 
rats treated with cisplatin (Group II) as compared to normal control 
(Group I).  
In rats treated with cisplatin along with silymarin (Group V), there 
was a significant (p˂0.05) decrease in lipid peroxidation  and 
significant (p˂ 0.05) increase in glutathione reductase as compared 
to only cisplatin-treated rats (Group II). However, In rats treated 
with cisplatin with silver nanoparticles of silymarin (Group VI), 
there was a profound and more significant (p˂ 0.05) changes in lipid 
peroxidation and renal enzymatic antioxidants were found as 
compared to only cisplatin-treated rats (Group II) as well as compared 
to rats treated with cisplatin along with silymarin (Group V) and the 
values were restored near to normal level which indicated the 
profound, significant effect of silver nanoparticles of silymarin.  
There was no significant (p˂0.05) change in ser um kidney 
markers, lipid peroxidation and renal enzymatic antioxidants also 
observed in groups with only silymarin treated rats (Group III) 
and silver nanoparticles of silymarin only treated rats (Group IV) 
as compared to normal control rats (Group I) which showed the 
there was no adverse effect of silymarin and its silver 
nanoparticles in albino rats. 
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Fig. 6: Effect of silver nanoparticles of silymarin on renal oxidative stress markers in different experimental groups, all values were 
expressed as mean±SD (n = 6). Statistically significant of *ap<0.05 and *bp<0.05 compared to Normal control group (I), *cp<0.05 compared 
to cisplatin-treated group (II) and *d
 
Effect of silver nanoparticles of silymarin on histopathological 
examination 
p<0.05 compared to cisplatin-treated group (II) and silymarin along with cisplatin treated group (V), 
same superscript letters were not significantly (p 0˂.05) different from each other 
Fig. 7 (A-F) revealed that the effect of silver nanoparticles of silymarin 
on histopathological changes of different experimental groups. The 
cortex and medulla are identifiable. The cortex shows normal 
glomeruli, tubules, interstitium and blood vessels in kidney of normal 
control rat (Group I). The glomeruli vary from normal to atrophic. 
There is extensive tubular necrosis characterized by sloughing of the 
epithelium. The tubular lamina show many desquamated epithelial 
cells in the kidney of cisplatin-treated rats (Group II). In silymarin 
alone treated rat (Group III) and in nanoparticles of silymarin alone 
treated rat (Group IV), the cortex and medulla are identifiable. The 
cortex shows normal glomeruli, tubules, interstitium and blood 
vessels. There are no pathological changes in kidney. In kidney of rat 
treated with cisplatin along with silymarin (Group V) the glomeruli are 
completely normal. There is reversal of tubular necrosis. Hence, all the 
tubules appear normal. There is no evidence of eosinophilic hyaline 
casts of in the collecting ducts. The interstitium and blood vessels are 
normal. But, in the kidney of rat treated with cisplatin along with silver 
nanoparticles of silymarin (Group VI), we found that profound and 
significant changes in the glomeruli are completely normal. There is a 
complete reversal of tubular necrosis. Hence, all the tubules appear 
normal. There is no evidence of eosinophilic hyaline casts of in the 
collecting ducts. The interstitium and blood vessels are normal than in 
the kidney of rat treated with cisplatin along with silymarin (Group V). 
Urea and creatinine level in serum is considered as indicators of 
renal function. Urea is the principal nitrogen-containing product of 
protein metabolism while uric acid is considered as the key 
metabolic product of purine nucleotides that is usually excreted in 
the urine. In renal disorder, the production rate of serum urea 
exceeds the renal clearance rate; hence urea accumulates in serum. 
Creatinine is generally derived from endogenous sources by the 
breakdown of tissue creatine. Our results were revealed that 
cisplatin produced a significant elevation in serum creatinine, urea 
and uric acid levels. The increased urea, uric acid, and creatinine 
levels suggest the reduction of glomerular filtration rate [34]. In 
contrast, silver nanoparticles of silymarin treated rats showed 
significant ameliorate these markers, thus showing their ability to 
protect against cisplatin-induced kidney. From this study, we also 
found that the adverse effect of cisplatin was restored by silver 
nanoparticles of silymarin.  
 
 
Fig. 7(A-F): Light micrographs of renal tissue of different experimental group of rats (HEx400). A (Group I): Histopathological view of 
renal sections of Normal control rats showing normal organization of tubular lining epithelial cells (T and arrows) and glomeruli (G). B 
(Group II): Histopathological view of renal sections of cisplatin-treated rats showing severe congestion in glomeruli (G) and 
disappearance of lining epithelium in tubular cells (T and arrows). C (Group III): Histopathological view of renal sections of silymarin 
treated rats showing normal organization of tubular lining epithelial cells (T and arrows) and glomeruli (G). D (Group IV): 
Histopathological view of renal sections of silver nanoparticles of silymarin treated rats showing normal organization of tubular lining 
epithelial cells (T and arrows) and glomeruli (G). E (Group V): Histopathological view of renal sections of silymarin treated in cisplatin-
induced rats showing regenerative changes in lining epithelium of tubules (T and arrows) and glomeruli (G). F (Group VI): 
Histopathological view of renal sections of silver nanoparticles of silymarin treated in cisplatin-induced rats showing regenerative 
changes in lining epithelium of tubules (T and arrows) and glomeruli (G) 
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This result was supported with previous studies on the protection of 
curcumin and curcumin nanoparticles against cisplatin-induced 
nephrotoxicity in male rats by Soheir et al.,(2014) [35]. 
Furthermore, our results also revealed that cisplatin caused a 
significant decline in the activity of the antioxidant enzymes like 
glutathione reductase and enhancement of MDA production in the 
renal tissue. It was evident that cisplatin nephrotoxicity occurs as a 
result of oxidative stress and increased generation of superoxide 
anion, hydrogen peroxide, and hydroxyl radicals due to the 
increased activity of NADPH oxidase, xanthine oxidase, and 
adenosine deaminase [36]. These free radicals damage the lipid 
components of the cell membrane via peroxidation and denaturing 
its proteins, which subsequently lead to enzymatic inactivation [37]. 
We confirmed the protective impact of silver nanoparticles of 
silymarin by restored the normal levels of all biochemical profile 
and exhibited the antioxidant impact of silver nanoparticles of 
silymarin against cisplatin-induced nephrotoxicity in rats by 
increasing the levels of enzymatic antioxidants such as glutathione 
reductase. 
These findings were consistent with previous studies by Ali et al.,(2007) 
on the ameliorative effect of cysteine prodrug L-2-oxothiazolidine-4-
carboxylic acid on cisplatin-induced nephrotoxicity in rats [38]. 
Additionally, the above findings were supported by the treatment with 
silver nanoparticles of silymarin after cisplatin administration prevented 
the renal tubular damage and preserved the normal histological features 
of renal tubules. This findings were accordance with Mustafa et 
al.,(2016) who have reported on potential therapeutic effects of 
silymarin and silymarin-loaded solid lipid nanoparticles on experimental 
kidney damage in BALB/c mice: biochemical and histopathological 
evaluation [39]. 
CONCLUSION 
From this study, we have concluded that the characterization of 
silver nanoparticles study revealed the nanosize of particle 
synthesized from silymarin which indicates the potential of 
silymarin from reduce of Ag ions into Ag nanoparticles. Animal 
experiment study revealed that the silver nanoparticles of silymarin 
was found to be more significant effective in restoration of kidney 
from adverse effect caused by cisplatin than silymarin alone, which 
can be attributed to the slow and regular release of silymarin by 
nanoparticles providing silymarin with a rise in bioavailability, 
which, in turn, improves its therapeutic effects. The above findings 
were supported by histopathological examination revealed that the 
amelioration effect of silver nanoparticles of silymarin in cisplatin-
treated groups. Thus, silver nanoparticles synthesized from 
silymarin could be beneficial for patients were treated with cisplatin 
drug for the prevention of nephrotoxicity. 
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